Full Name
Dr. Joris Vandeputte
Job Title
Former President International Alliance For Biological Standardisation (IABS) And IABS-EU
Hospital/Organisation/Company
IABS
Speaker Bio
Doctor in Veterinary Medicine, virologist, specialized in vaccines and human/animal infectious diseases, "One Health" approach, collaborations with the EU, WHO, and Asian and African authorities, focalising on innovation and pandemic preparedness, regulatory impact.
CV Highlights:
• Virology research at Ghent University, Faculty of Veterinary Medicine: porcine and bovine herpesviruses; discovery of the H1N1 influenza virus in pigs and its mixing vessel role, in collaboration with the WHO Reference Centre in Munich.
• Industry: I. Mérieux: Global Head of Swine and Ruminant Vaccine Units, Scientific Director, International Regulatory Affairs Director at Rhône-Mérieux/Merial (now Boehringer Ingelheim), flu vaccines both animals and human
• Global Health: Member of the founding team of GAVI/The Vaccine Fund (the Global Alliance for Vaccines and Immunization), officially launched in Davos in January 2000. Established a lasting partnership between GAVI/The Vaccine Fund and the European Union.
• Human tuberculosis vaccines: Vice President for resource mobilization and development support for TB vaccines at TBVI (Tuberculosis Vaccine Initiative).
• Laboratory network in Africa: Initiated a livestock vaccine production network in Africa for the global organization GALVMED, funded by the European Union.
• European research programs: Regulatory Affairs Lead for EU/IMI projects including ZAPI (platform technologies for human and animal vaccines; pandemic preparedness), VAC2VAC (replacement of laboratory animals), and MANCO (development of monoclonal antibodies against COVID). Regulatory affairs co-lead in EU/IMI projects DRIVE (influenza vaccine effectiveness), INNO4VAC (human infection models), CEPI MUSICC a global consortium on controlled human infection studies for COVID, ASFaVIP, HORIZON EU project on vaccines for African Swine Fever.
• Pandemic preparedness: member of Corona virus library group at CEPI; strategies for pandemic preparedness known viruses and disease X.
• Global plan to eliminate rabies by 2030: input into the "Zero Rabies by 2030" global plan, a joint initiative by the WHO, OMSA (formerly OIE), FAO, and GARC.
• President of the IABS (International Alliance for Biological Standardization) from 2016 to 2022; IABS board member; advisor to vaccine companies and various disease control initiatives. Founding president of IABS-EU
• Member of the World Vaccine Congress advisory board.
CV Highlights:
• Virology research at Ghent University, Faculty of Veterinary Medicine: porcine and bovine herpesviruses; discovery of the H1N1 influenza virus in pigs and its mixing vessel role, in collaboration with the WHO Reference Centre in Munich.
• Industry: I. Mérieux: Global Head of Swine and Ruminant Vaccine Units, Scientific Director, International Regulatory Affairs Director at Rhône-Mérieux/Merial (now Boehringer Ingelheim), flu vaccines both animals and human
• Global Health: Member of the founding team of GAVI/The Vaccine Fund (the Global Alliance for Vaccines and Immunization), officially launched in Davos in January 2000. Established a lasting partnership between GAVI/The Vaccine Fund and the European Union.
• Human tuberculosis vaccines: Vice President for resource mobilization and development support for TB vaccines at TBVI (Tuberculosis Vaccine Initiative).
• Laboratory network in Africa: Initiated a livestock vaccine production network in Africa for the global organization GALVMED, funded by the European Union.
• European research programs: Regulatory Affairs Lead for EU/IMI projects including ZAPI (platform technologies for human and animal vaccines; pandemic preparedness), VAC2VAC (replacement of laboratory animals), and MANCO (development of monoclonal antibodies against COVID). Regulatory affairs co-lead in EU/IMI projects DRIVE (influenza vaccine effectiveness), INNO4VAC (human infection models), CEPI MUSICC a global consortium on controlled human infection studies for COVID, ASFaVIP, HORIZON EU project on vaccines for African Swine Fever.
• Pandemic preparedness: member of Corona virus library group at CEPI; strategies for pandemic preparedness known viruses and disease X.
• Global plan to eliminate rabies by 2030: input into the "Zero Rabies by 2030" global plan, a joint initiative by the WHO, OMSA (formerly OIE), FAO, and GARC.
• President of the IABS (International Alliance for Biological Standardization) from 2016 to 2022; IABS board member; advisor to vaccine companies and various disease control initiatives. Founding president of IABS-EU
• Member of the World Vaccine Congress advisory board.
